BeOne Medicines Ltd. SEC filings ONC
BeOne Medicines Ltd. has 1,002 filings in SEC EDGAR's recent list, going back to Nov 19, 2018. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Jun 11, 2026 | — |
| S-3ASR | Automatic shelf registration | May 6, 2026 | — |
| S-3ASR | Automatic shelf registration | May 6, 2026 | — |
| POS AM | Filing | May 27, 2025 | — |
| S-8 POS | Filing | May 27, 2025 | — |
| S-8 POS | Filing | May 27, 2025 | — |
| S-8 POS | Filing | May 27, 2025 | — |
| S-8 POS | Filing | May 27, 2025 | — |
| S-8 POS | Filing | May 27, 2025 | — |
| S-8 POS | Filing | May 27, 2025 | — |
| S-8 POS | Filing | May 27, 2025 | — |
| S-8 POS | Filing | May 27, 2025 | — |
| S-8 POS | Filing | May 27, 2025 | — |
| F-6/A | Filing | May 1, 2025 | — |
| F-6 | Filing | Apr 24, 2025 | — |
| 424B3 | Prospectus | Mar 10, 2025 | — |
| S-4/A | Filing | Feb 28, 2025 | — |
| S-4/A | Filing | Jan 21, 2025 | — |
| S-4 | Registration for a merger or exchange | Aug 7, 2024 | — |
| S-8 | Employee stock plan registration | Jun 5, 2024 | — |
| S-3ASR | Automatic shelf registration | May 9, 2023 | — |
| S-3ASR | Automatic shelf registration | May 9, 2023 | — |
| S-8 | Employee stock plan registration | Aug 8, 2022 | — |
| 424B5 | Prospectus supplement | Dec 1, 2021 | — |
| 424B5 | Prospectus supplement | Nov 23, 2021 | — |
| 424B7 | Filing | Dec 2, 2020 | — |
| 424B7 | Filing | Dec 1, 2020 | — |
| S-8 | Employee stock plan registration | Aug 6, 2020 | — |
| 424B2 | Prospectus | Jul 13, 2020 | — |
| S-3ASR | Automatic shelf registration | May 11, 2020 | — |
| S-3ASR | Automatic shelf registration | May 11, 2020 | — |
| S-8 | Employee stock plan registration | Dec 13, 2018 | — |
Showing 32 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ONC (Nasdaq), BEIGF (OTC)
- Fiscal year ends
- December 31
- Headquarters
- Basel
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1651308
- Former names
- BeiGene, Ltd. (until May 27, 2025)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.